Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes

Environment International(2020)10.1016/j.envint.2020.105935Source: DataRank Database

Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes is a research paper published in Environment International (2020). On theSindex it has a DataRank of 0. It has been cited 63 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access63 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (22)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Tim Sinioja ORCID,Santosh Lamichhane ORCID,Partho Sen ORCID,Johanna Bodin ORCID,Heli Siljander ORCID

Live enrichment

PubMed:32634666

Research Council of Finland

Grant: 292568

Personalised medicine to predict and prevent Type 1 Diabetes / Consortium: P4 Diabetes

National Institutes of Health

Grant: 1DP3DK094338-01

Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity: Potential M

Swedish Research Council

Grant: unidentified

unidentified

goldLicense: CC BY

https://doi.org/10.1101/588350

https://doi.org/10.1016/j.envint.2020.105935

https://pubmed.ncbi.nlm.nih.gov/32634666

http://juuli.fi/Record/0369526120

http://juuli.fi/Record/0373984620

Fields of Study

0303 health sciences03 medical and health sciences

Keywords

FluorocarbonsMass spectrometryPFASta1172ta1182ta3123Bile acidsDiabetes Mellitus, ExperimentalEnvironmental sciencesType 1 diabetesDiabetes Mellitus, Type 1PregnancyPrenatal Exposure Delayed EffectsLipidomicsAnimalsGE1-350Environmental PollutantsFemaleFinlandPhospholipids

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health

Additional file 1 of Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

10.6084/m9.figshare.17273245.v1figshare

Additional file 1 of Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride

10.6084/m9.figshare.17273245figshare

Additional file 1 of Association of Perfluoroalkyl and polyfluoroalkyl substances (PFASs) exposures and the risk of systemic lupus erythematosus: a case–control study in China

10.6084/m9.figshare.24515944.v1figshare

Additional file 1 of Association of Perfluoroalkyl and polyfluoroalkyl substances (PFASs) exposures and the risk of systemic lupus erythematosus: a case–control study in China

10.6084/m9.figshare.24515944figshare